Zentiva
Steffen Saltofte is the current CEO of Zentiva, with previous experience as the CEO of ACINO and Chief Operating Officer at Boehringer Ingelheim. Prior to these roles, held positions at Merial and Syngenta. Steffen also has experience as an M&A Integration Manager and General Manager at Maersk Line and Maersk Sealand. Saltofte holds an MBA in Business Administration from IMD, as well as degrees in International Business and Strategic Market Management.
This person is not in any offices
Zentiva
5 followers
Zentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe. We are a team of almost 5,000 unique talents bonded together by our mission to deliver high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability.